Medikly, a health IT startup with a platform designed to help pharmaceutical marketers locate their customer base on social media is expanding into the clinical trial space thanks to a strategic partnership with inVentiv Health, which will help speed up clinical trials.
The agreement gives inVentiv Health exclusive access to Medikly’s platform and data-collection tools that help pharmaceutical companies find and engage clinical trial investigators. It gives a real-time view of doctors based on their preferences and behaviors online.
The technology enables trial sponsors to:
- Create communities for investigators
- Develop relevant and sophisticated medical education programs
- Measure and apply engagement metrics to understand how healthcare providers will respond to messages
- Allow a pharmaceutical company to expand trial awareness, build trust with physicians, accelerate acquisition rates and improve relationships to optimize engagement
The agreement expands Medikly’s platform into the $2.3 billion business segment of clinical trial support.
“By now, we all know that digital technologies can streamline clinical trials and save costs, but the challenge is knowing which technologies to use and how to best deploy them to save the most money and time,” said Raymond Hill, executive vice president of clinical for inVentiv Health.
The Blueprint Health accelerator graduate raised $1.2 million in a series A financing round earlier this year. Medikly’s core customers are pharmaceutical marketers who use the platform to identify and understand nurse and physician behavior patterns and relationships.
There are plenty of companies seeking to improve clinical trial recruitment online particularly through social media, but it’s mainly for patient recruitment.
[Employment photo from BigStock]